Senior PRO Strategy Director — Oncology (Remote)

Openkrill; United States; Remote; USD 232,000 - 290,000; Full time

Job summary

Revolution Medicines is a global oncology company focused on RAS-addicted cancers, advancing oral RAS(ON) inhibitors. The Senior Director, Patient-Reported Outcomes (PRO) provides strategic PRO expertise across development, regulatory, and market access objectives while guiding PRO evidence generation and dissemination.

The role demands leadership in PRO strategy, strong cross-functional collaboration, and expertise in translating PRO concepts for regulatory submissions and publications.

Qualifications

• Advanced degree in psychology, psychometrics, epidemiology, public health, health outcomes research, behavioral science, or related field.
• Minimum 13 years of PRO or related experience in pharma/biotech/CRO/consulting/academia.
• Proven ability to develop and implement PRO strategies for late-stage development and regulatory interactions.

Responsibilities

• Develop and lead PRO strategy for assigned programs aligned with regulatory objectives.
• Select, validate, and interpret PRO measures and endpoints.
• Collaborate with cross-functional teams to integrate PRO into study designs and analyses.
• Oversee qualitative and quantitative PRO research activities and manage external vendors.
• Provide methodological guidance on PRO endpoints, meaningful change, and interpretation.
• Support regulatory submissions and interactions with HTA bodies; engage external experts as needed.
• Disseminate PRO evidence through reports, publications, and presentations.
• Coach colleagues and help establish best practices for patient-focused development.

Skills

PRO methodologies (qualitative)

PRO methodologies (quantitative)

Cross-functional collaboration

Scientific communication

Study design input & interpretation

Education

Advanced degree in health outcomes/related field

13+ years PRO experience

Job description

Revolution Medicines is a global oncology company focused on RAS-addicted cancers, advancing oral RAS(ON) inhibitors. The Senior Director, Patient-Reported Outcomes (PRO) provides strategic PRO expertise across development, regulatory, and market access objectives while guiding PRO evidence generation and dissemination.

The role demands leadership in PRO strategy, strong cross-functional collaboration, and expertise in translating PRO concepts for regulatory submissions and publications.